Is This Biotech Stock a Rising Star in the Making?

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech stock gain prominence? Let’s find…

The Calm Before the NEXT Stock Storm

On the surface stocks just seem to be trading calmly in a trading range. Under the surface things are setting up for continuation of the bear market which is why UBS now predicts market bottom around 3,200 for the S&P 500 (SPY). Get 40 year investment veteran, Steve Reitmeister’s, updated market outlook, trading plan and…

Want to Boost Sales This Holiday Season? Here Are 5 Ways to Prepare for a Successful Holiday Email Marketing Campaign

Opinions expressed by Entrepreneur contributors are their own. If you’re betting on email to boost sales this holiday season, you have the right mindset. Last year, online retail sales grew 11.3% over 2020 to more than $218 billion, according to the National Retail Federation. Although the ease of pandemic restrictions will bring more people to…